Eventos adversos por exanguinotransfusión

1. Steiner LA, Bizzarro MJ, Ehrenkranz RA, Gallagher PG. A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality. Pediatrics 2007;120:27-32.

2. Stockman JA 3rd. Overview of the state of the art of rh disease: History, current clinical management, and recent progress. J Pediatr Hematol Oncol 2001;23:385-93.

3. Maisels MJ. Phototherapy – Traditional and nontraditional. J Perinatol 2001;21 Suppl 1:S93-7.

4. Thayyil S, Milligan DW. Single versus double volume exchange transfusion in jaundiced newborn infants. Cochrane Database Syst Rev 2006;(4):CD004592.

5. Murki S, Kumar P. Blood exchange transfusion for infants with severe neonatal hyperbilirubinemia. Semin Perinatol 2011;35:175-84.

6. Hakan N, Zenciroglu A, Aydin M, Okumus N, Dursun A, Dilli D, et al. Exchange transfusion for neonatal hyperbilirubinemia: An 8-year single center experience at a tertiary neonatal intensive care unit in turkey. J Matern Fetal Neonatal Med 2015;28:1537-41.

7. Chitlangia M, Shah G, Poudel P, Mishra OP. Adverse Events of Exchange Transfusion in Neonatal Hyperbilirubinemia. J Nepal Paediatr Soc 2014;34:7-13. Available from: http://www.nepjol. info/index.php/JNPS/article/view/9030. [Last accessed on 2018 Jul 07].

8. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316.

9. Maisels MJ, Watchko JF, Bhutani VK, Stevenson DK. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. J Perinatol 2012;32:660-4.

10. Iskander I, Gamaleldin R, El Houchi S, El Shenawy A, Seoud I, El Gharbawi N, et al. Serum bilirubin and bilirubin/albumin ratio as predictors of bilirubin encephalopathy. Pediatrics 2014;134:e1330-9.